Jin Bo, Wang Richard Y, Qiu Qi, Sugauchi Fuminaka, Grandinetti Teresa, Alter Harvey J, Shih J Wai-Kuo
Infectious Disease Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Immunology. 2007 Sep;122(1):15-27. doi: 10.1111/j.1365-2567.2007.02607.x. Epub 2007 Apr 23.
Double-stranded RNA is produced during virus replication and, together with the viral antigen, is responsible for inducing host antivirus immunity. The hepatitis C virus (HCV) non-structural protein-3 (NS3) has been implicated in the immune evasion of HCV, and is one of the prime targets for inducing immunity against HCV infection. Mice were immunized with recombinant NS3 protein (rNS3) and poly (I:C) emulsified in Montanide ISA 720 (M720). Cytokine production was assayed by enzyme-linked immunospot assay, and CD4(+) IFN-gamma(+) T helper (Th) cells or CD8(+) IFN-gamma(+) cytotoxic T lymphocytes were detected by flow cytometry. Anti-NS3 titre and immunoglobulin G2a (IgG2a) and IgG1 levels were monitored by enzyme-linked immunosorbent assay. Administration of rNS3 formulated in poly (I:C) and M720 induced anti-NS3 titres with a predominantly IgG2a isotype comparable to those induced by rNS3 in CpG-ODN and M720. The cytokine profiles showed that this formulation induced a Th1-biased immune response with several-fold more interferon-gamma (IFN-gamma)-producing cells than interleukin-4-producing cells. In contrast, rNS3 in M720 induced a Th2-biased immune response. The frequency of IFN-gamma-producing CD4(+) and CD8(+) cells induced by rNS3 in poly (I:C) and M720 was significantly higher than that induced by rNS3, rNS3 in M720, or rNS3 in poly (I:C), and was comparable to that induced by rNS3 in CpG-ODN with M720. The antigen-specific CD8(+) T-cell immune response persisted for up to 7 months after immunization. In conclusion, poly (I:C) with rNS3 in M720 can elicit a strong and persistent Th1-biased immune response and a cytotoxic T-lymphocyte response through cross-priming in mice. This study highlighted a promising formulation for inducing an efficient cellular immune response against HCV that has potential for HCV vaccine development.
双链RNA在病毒复制过程中产生,并与病毒抗原一起负责诱导宿主抗病毒免疫。丙型肝炎病毒(HCV)非结构蛋白3(NS3)与HCV的免疫逃逸有关,是诱导针对HCV感染免疫的主要靶点之一。用重组NS3蛋白(rNS3)和乳化于Montanide ISA 720(M720)中的聚肌胞苷酸(poly (I:C))对小鼠进行免疫。通过酶联免疫斑点试验测定细胞因子的产生,并通过流式细胞术检测CD4(+) IFN-γ(+)辅助性T细胞(Th)或CD8(+) IFN-γ(+)细胞毒性T淋巴细胞。通过酶联免疫吸附试验监测抗NS3滴度以及免疫球蛋白G2a(IgG2a)和IgG1水平。用poly (I:C)和M720配制的rNS3诱导产生的抗NS3滴度,其主要的IgG2a同种型与rNS3在CpG-ODN和M720中诱导产生的滴度相当。细胞因子谱显示,该制剂诱导了以Th1为主的免疫反应,产生干扰素-γ(IFN-γ)的细胞比产生白细胞介素-4的细胞多几倍。相比之下,M720中的rNS3诱导了以Th2为主的免疫反应。rNS3在poly (I:C)和M720中诱导产生的产生IFN-γ的CD4(+)和CD8(+)细胞的频率显著高于rNS3、M720中的rNS3或poly (I:C)中的rNS3诱导产生的频率,并且与rNS3在CpG-ODN和M720中诱导产生的频率相当。抗原特异性CD8(+) T细胞免疫反应在免疫后持续长达7个月。总之,M720中与rNS3结合的poly (I:C)可通过小鼠体内的交叉呈递引发强烈且持久的以Th1为主的免疫反应和细胞毒性T淋巴细胞反应。本研究突出了一种有前景的制剂,可诱导针对HCV的高效细胞免疫反应,具有开发HCV疫苗的潜力。